Delivery Order SPE2DB22D1017-SPE2DB25FYPCC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,234.32 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.00 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication commonly used in diabetes management, aligning with...
- The Defense Logistics Agency awarded a delivery order valued at $7,701.70 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical will be supplied from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and represents a small-value...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.27 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a ceiling value of $16,657.53 under a firm fixed-price contract type. This is a non-set-aside competitive award, with performance to be completed by August 25, 2025, and fulfillment occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes...
- The Defense Logistics Agency awarded a delivery order valued at $8,482.69 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,954.01 on July 18, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price, competitively awarded contract represents a non-set-aside delivery order with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPCCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $23,355.68 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent with AmerisourceBergen's established role as a major pharmaceutical distributor supporting federal medical procurement needs. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and other government healthcare systems worldwide. AmerisourceBergen's continued selection for federal pharmaceutical delivery reflects its demonstrated capability to compete successfully and meet DLA's rigorous procurement standards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 8/25/25 |